Pontifax
Biotech Investor · 3 portfolio companies
Portfolio
3
Combined Value
$1.5B
Focus Areas
8
Top Stage
Commercial
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| UroGen Pharma | $857.8M |
| Agomab Therapeutics | $600.0M |
| Regentis Biomaterials | $15.7M |